Skip to content
Home/Companies/Biotech/Nuntius Therapeutics
Nuntius Therapeutics

Nuntius Therapeutics

Biotech·UK·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Nuntius Therapeutics?

Nuntius Therapeutics is currently owned by BACKED VC through Backed Fund II (2022 vintage), since 2021.

Hand-verified · updated 2026-05-27

BACKED VC
Investor
BACKED VC
Backed Fund II · 2022 · VC

Key facts

HQUK
SectorBiotech
StatusActive
Websitewww.nuntiustx.com

More from Backed Fund II

Other portfolio companies in the same fund.

Auctor
Auctor
Active
FintechSingapore· 2022
BCB Group
BCB Group
Active
FintechUK· 2022
CoSyne Therapeutics
CoSyne Therapeutics
Active
BiotechUK· 2022
Footium
Footium
Active
GamingUK· 2022
Laguna Games
Laguna Games
Active
GamingUSA· 2022
Onramper
Onramper
Active
FintechNetherlands· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Nuntius Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Nuntius Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue